Gene expression profile of endothelin-1-induced growth in glomerular mesangial cells

American Journal of Physiology - Cell Physiology

Volumn 285, Issue 5 54-5, 2003, Pages

  Mishra, Rangnath ^a   Leahy, Patrick ^a   Simonson, Michael S ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Heparin binding epidermal growth factor like growth factor; Microarray; Proliferation

Indexed keywords

ENDOTHELIN 1; FIBROBLAST GROWTH FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; PROTEIN BAX; PROTEIN P27;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; MESANGIUM; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EUKARYOTA;

EID: 0142084719     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00105.2003     Document Type: Article

References (33)

1. Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T, Ohmoto H, Node K, Yoshino K, Ishiguro H, Asanuma H, Sanada S, Matsumura Y, Takdeda H, Beppu S, Tada M, Hori M, and Higashiyama S. Cardiac hypertrophy is inhibited by antagonism of ADAM 12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med 8: 35-40, 2002.
2. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, and Sherlock G. Gene Ontology: tool for the unification of biology. Nat Genet 25: 25-29, 2000.
3. Benigi A. Endothelin antagonists in renal disease. Kidney Int 57: 1778-1794, 2000.
4. Boffa JJ, Tharaux P, Dussaule JC, and Chatziantoniou C. Regression of renal vascular fibrosis by endothelin receptor antagonism. Hypertension 37: 490-496, 2001.
5. Chatziantoniou C, Boffa JJ, Ardailou R, and Dussaule JC. Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice: role of endothelin. J Clin Invest 101: 2780-2789, 1998.
6. Daub H, Wallasch C, Lankenau A, Herrlich A, and Ullrich A. Signal characteristics of G protein-transactivated EGF receptor. EMBO J 16: 7032-7044, 1997.
7. Della Rocca G, Maudsley S, Daaka Y, Lefkowitz RJ, and Luttrell LM. Pleiotropic coupling of G protein-coupled receptors to the mitogen-activated protein kinase cascade. Role of focal adhesions and receptor tyrosine kinases. J Biol Chem 274: 13978-13984, 1999.
8. Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7: 2495-2508, 1996.
9. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, Marumo F, and Inagami T. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 273: 8890-8896, 1998.
10. Eisen MB, Spellman PT, Brown PO, and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863-14868, 1998.
11. Fakhouri F, Placier S, Ardaillou R, Dussaule JC, and Chatziantoniou C. Angiotensin II activates collagen type I gene in renal cortex and aorta of transgenic mice through interaction with endothelin and TGFβ. J Am Soc Nephrol 12: 2701-2710, 2001.
12. Goishi K, Higashiyama S, Klagsbrun M, Nakano N, Umata T, Ishikawa M, Mekada E, and Taniguchi N. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol Biol Cell 6: 967-980, 1995.
13. Herman WH, Emancipator SN, Rhoten RL, and Simonson MS. Vascular and glomerular expression of endothelin-1 in normal human kidney. Am J Physiol Renal Physiol 275: F8-F17, 1998.
14. Hocher B, Thone-Reineke C, Rohmeiss P, Schmager F, Slowinski T, Burst V, Siegmund F, Quertermous T, Bauer C, Neumayer H, Schleuning WD, and Theuring F. Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest 99: 1380-1389, 1997.
15. Hunley TE and Kon V. Update on endothelins - biology and clinical implications. Pediatr Nephrol 16: 752-762, 2001.
16. Iwamoto R and Mekada E. Heparin-binding EGF-like growth factor: a juxtacrine growth factor. Cytokine Growth Factor Rev 11: 335-344, 2000.
17. Kedzierski RM and Yanagisawa M. Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 41: 851-876, 2001.
18. Kirchengast M and Munter K. Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling. Proc Soc Exp Biol Med 221: 312-325, 1999.
19. Kyriakides TR, Zhu YH, Smith LT, Bain SD, Yang Z, Lin MT, Danielson KG, Iozzo RV, LaMarca M, McKinney CE, Ginns EI, and Bornstein P. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol 140: 419-430, 1998.
20. Levitzki A and Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 267: 1782-1788, 1995.
21. Li X, Lee JW, Graves LM, and Earp HS. Angiotensin II stimulates ERK via two pathways in epithelial cells: protein kinase C suppresses a G-protein coupled receptor-EGF receptor transactivation pathway. EMBO J 17: 2574-2583, 1998.
22. Luttrell LM, Della Rocca GJ, van Biesen T, Luttrell DK, and Lefkowitz RJ. Gβγ subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. J Biol Chem 272: 4637-4644, 1997.
23. Mishra R, Leahy P, and Simonson M. Gene expression profiling reveals role for EGF-family ligands in mesangial cell proliferation. Am J Physiol Renal Physiol 283: F1151-F1159, 2002.
24. Miyauchi T and Masaki T. Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol 61: 391-415, 1999.
25. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, and Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402: 884-888, 1999.
26. Raab G and Klagsbrun M. Heparin-binding EGF-like growth factor. Biochim Biophys Acta 1333: F179-F199, 1997.
27. Schlessinger J. How receptor tyrosine kinases activate Ras. Trends Biochem Sci 18: 273-275, 1993.
28. Schultz PJ, DiCorleto PE, Silver BJ, and Abboud HE. Mesangial cells express PDGF mRNAs and proliferate in response to PDGF. Am J Physiol Renal Fluid Electrolyte Physiol 255: F674-F684, 1988.
29. Shaw J, Akiyoshi D, Arrigo D, Rhoad A, Sullivan B, Thomas J, Genbauffe F, Bacha P, and Nichols J. Cytotoxic properties of DAB 486EGF and DAB389EGF, epidermal growth factor receptor-targeted fusion toxins. J Biol Chem 266: 21118-21124, 1991.
30. Shindo T, Kurihara H, Maemura K, Kurihara Y, Ueda O, Suzuki H, Kuwaki T, Ju KH, Wang Y, Ebihara A, Nishimatsu H, Moriyama N, Fukuda M, Akimoto Y, Hirano H, Morita H, Kumada M, Yazaki Y, Nagai R, and Kimura K. Renal damage and salt-dependent hypertension in aged transgenic mice overexpressing endothelin-1. J Mol Med 80: 105-116, 2002.
31. Simonson M. Cell signaling by endothelin peptides. In: Endothelin and Its Inhibitors, edited by T. Warner. Berlin: Springer, 2001, p. 115-140.
32. Tusher VG, Tibshirani R, and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001.
33. Umeda Y, Miyazaki Y, Shiinoki H, Higashiyama S, Nakanishi Y, and Hieda Y. Involvement of heparin-binding EGF-like growth factor and its processing by metalloproteinases in early epithelial morphogenesis of the submandibular gland. Dev Biol 237: 202-211, 2001.